School of Medicine
Showing 1-10 of 46 Results
-
Mark A. Cappelli
Professor of Mechanical Engineering
BioProfessor Cappelli received his B.Sc. degree in Physics (McGill, 1980), and M.A.Sc and Ph.D. degrees in Aerospace Sciences (Toronto, 1983, 1987). He joined Stanford University in 1987 and is currently a Professor in the Department of Mechanical Engineering and Co-Director of the Engineering Physics Program. He carries out research in applied plasma physics with applications to a broad range of fields, including space propulsion, aerodynamics, medicine, materials synthesis, and fusion.
-
Ian Carroll, MD, MS
Associate Professor of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
On Partial Leave from 06/16/2025 To 07/21/2025Current Research and Scholarly InterestsWe are committed to promoting an understanding of cerebrospinal fluid (CSF) leaks, and ensuring that all patients who are suffering from cerebrospinal fluid leaks receive appropriate diagnosis and treatment of this devastating, chronic, and fixable condition. We believe this can be best accomplished in a multidisciplinary setting involving expertise in radiology, neurology, and interventional pain medicine.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Alma-Martina Cepika
Instructor, Pediatrics - Stem Cell Transplantation
Research Asst., Pediatrics - Hematology/OncologyCurrent Role at StanfordAs an Instructor at Stanford, working in the laboratory of cell and gene therapy pioneer Dr. Maria Grazia Roncarolo, Dr. Cepika co-led an acute myeloid leukemia (AML) project. She designed an RNA-sequencing-based "interactomics" assay, identifying CD200 overexpression and ICAM1 deficiency as mechanisms of AML resistance to T-cell killing, correlating with poor patient survival. Currently, she investigates regulatory T cell (Treg) biology and Treg subsets in health and disease. She has identified the mechanisms of suppression and long-term in vivo persistence of alloantigen-specific type 1 regulatory T (Tr1) cells, and is the lead scientist of the ongoing phase I/Ib clinical trial (ClinicalTrials.gov ID NCT04640987), testing these Tr1 cells as a therapy in leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Finally, her recent single-cell transcriptomic and epigenomic analyses identified key transcriptional regulators of human Tr1 cells and Tr1-like cells in human tumors.
-
Anne Lynn S. Chang, MD
Professor of Dermatology
Current Research and Scholarly InterestsMy two main research interests are:
1) To better understand and treat patients with aggressive basal and squamous cell carcinomas
2) To better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients, particularly skin cancer and rosacea -
Howard Y. Chang, MD, PhD
Virginia and D. K. Ludwig Professor of Cancer Research, Professor of Genetics and, by courtesy, of Pathology
On Leave from 12/16/2024 To 12/15/2026Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.
